Core Viewpoint - 康龙化成 confirmed its production cooperation with a leading international pharmaceutical company's Chinese subsidiary is part of its routine business operations [1] Group 1: Company Operations - The cooperation is established during the company's normal business activities to advance its development goals [1] - The company engages in collaborations with various companies across different sectors as part of its operational strategy [1] Group 2: Disclosure and Compliance - 康龙化成 is not aware of any information that needs to be disclosed to prevent the creation of a false market for its securities [1] - The company does not possess any insider information that requires disclosure under the relevant listing rules and regulations [1]
康龙化成(03759):集团与不同领域的多家公司开展合作,以推进自身业务发展目标